Christmas is approaching and it is time to look back and reflect upon what has happened during the first year at K2. The institute was created on the basis of four clinical institutes and many of the efforts undertaken by the leadership have aimed to establish a common culture, and to introduce common routines and arrangements based on the best practices from the old institutes. Because of this many people have had to adapt to a new structure. I am impressed with how flexible many of you have been during this process.
K2 is now organized in 8 academic sections and 21 research groups, with leaders bestowed with mandates. A technician process has been effectuated based on a rationale for how many technical positions are tied to the various research groups. A strategy plan valid until 2015 has been created. The HSE council is up and running. The academic affairs section is joined with K1 and in total 82 courses are administered in medicine, odontology, pharmacy and nutrition.
There are currently 143 PhD candidates at K2 and a total of 26 public defences have been completed at the institute. The Emeriti have done an excellent job as custodes.
Financial constraints have been a recurrent issue throughout the year. Even though our finances are still tight, we can rejoice in the fact that the situation is now markedly better than it was just a few months ago.
These are just a few keywords covering what has happened this year. There are still many challenges that await us, but for now we can all look forward to Christmas with a good conscience.
Last week we received the sad message that Senior Engineer Hildegunn Helle passed away, only 41 years old. This reminds us how fragile life is, and that despite all the happenings at the institute, it is far more important to have peace with oneself and ones nearest relatives and acquaintances.
I would like to take this opportunity to wish all of you a peaceful Christmas and a Happy new Year!
It was with great sadness that the Brest Cancer Group at Mohn Cancer Research Laboratory received the news that Hildegunn had passed away on the evening of December 10. Her death was not unexpected; we knew she was seriously ill and that this was inevitable. However, as she quietly passed away on Monday evening in her own home surrounded by her closest family it was a dignified and good ending to a prolonged illness.
Hildegunn arrived in our group in 1995; and except for natural leaves of absence due to three child births, she was working continuously in our group until her illness made this physically impossible. She belonged to the group of veterans joining us early and working with us up until what the group has become today. Hildegunn excelled from the beginning as a highly skilled coworker. In the beginning she was among those developing our new assays for high-sensitive estrogen-measurements, and this work would later prove decisive in the understanding, and use of, the new aromatase inhibitors, which today is standard treatment for hundreds of thousands of women with breast cancer worldwide. Later she participated in the pioneer-work related to the development of biobanks in addition to performing a number of other analytical tasks. She was one of the key staff members during the planning and furnishing of our new Mohn Cancer Research Laboratory. She was a coworker who never said no to new challenges; she knew her own skills, and she met new challenges with the attitude “I can’t do this, but given the opportunity I would love to learn this and do the task”. Knowledge and appliance of statistics for data-processing is one example, her commitment as HSE-representative is another; together these two examples illustrate the breadth of her work efforts and the skills of an unusually gifted person.
Above all she was one of the founding pillars in the good working environment we have enjoyed for many years in the group. Both as a role model and, not least, as a person actively taking part in the introduction and training of new personnel, she played a key role. Her winning personality and good sense of humor will always be remembered; she was not afraid to bring up problems, but she always did this in a constructive way. It was with great joy that we could formally promote her to senior engineer autumn 2012, a position suitable to the tasks she had executed in an outstanding way over several years.
It was not a coincidence that Hildegunn applied her work energy to cancer research. Through several performance assessments she genuinely expressed how meaningful she found her work. Hence it becomes even more meaningless that it was precisely a cancer disease which would end her life at an early age of 42.
We mourn Hildegunn’s passing. At the same time we are left with a warm memory, and a genuine thank for everything she was for us through all these years; both professionally and personally. Our thoughts are with Hildegunn’s closest family; Svein Inge, who has lost his life partner, and their three minor children who have lost their mother.
Per Eystein Lønning, Professor, K2
The Chemical Storage Facility will be closed from Monday 24/12, and will open again next year.
The calls for independent experts for Horizon 2020 have been published.
Click here for more information
Novo Nordisk Founden has two announcements – the Novo Nordic Excellence Project for young researchers in endocrinology, and the Clinical Research Fellowship Program at Steno Diabetes Center
The courses are free of charge for employees and students and UiB and HUS. Click here for this spring’s programme (In Norwegian)
Professor Harald G. Wiker has made an informative video on how to use My Space.
Click here to see the video (in Norwegian)
The Norwegian Cancer Society is cooperating with the Movember foundation to improve men’s health, especially in regard to prostate cancer. Application deadline is 23.01.2014.
The course will take place in February, 2014. Click here for more information (in Norwegian)
The events will take place on February 5-7. Click here for more information
Academy of Translational Medicine Professionals (ATMP) is working to set the standards for excellence in field of translational medicine. Professional certification program is designed to promote and maintain high quality in clinical research through the evaluation of the applicant’s translational medicine knowledge.
All employees having, or planning to have, external work employment must register this and apply for approval by 31.12.2013. This is done via PAGA. Please contact Elin Riple (email@example.com) if you have any problems with PAGA.
Every semester, the University of Bergen arrange a pedagogic course for group leaders (colloquium leaders, seminar leaders) having teaching tasks during the semester.
Click here for more information (In Norwegian)
Last weekend we witnessed an unusually active response to K2Nytt from many parts of the institute. You would think that it was the content of the newsletter which initiated a debate, but it was, in fact, the layout. The comments touched upon communist newspapers, and even Mao was brought up, and let the hundred flowers bloom. It is very nice that K2Nytt engages people, and several of the comments were indeed very good.
As for the layout of the newsletter it is, as Kristian pointed out, not just a simple matter of going back to the old format because the server on which this program was located, has been shut down. But most of us agree that they layout needs work, and the K2-group is working on this issue, so hold out, hold out.
Otherwise I hope that people will be just as engaged in paying attention to the content, as the presentation, of the material in K2Nytt. Comments are most welcome in the newsletter itself (yes, you may comment on each issue!) instead of through E-mails to everyone.
Friday Dec. 13 we witnessed a Saint Lucia parade thrugh the Lab-building. Here with Saint Lucia (Catalin Koro) and Santa Claus himself 🙂
The Estate and Facilities Management Division has posted information regarding mail routines and the Campus bus for Christmas. Click here for more information (in Norwegian)
Based on last week’s search of “ Departement of Clinical Science AND Bergen”. If you have publications which are not covered by this search, send the reference to firstname.lastname@example.org.
The conference will take place in Paris on June 25-27, 2014. Click here for more information
The “European Scienticfic Journal” (ESJ) is a double-blind peer reviewed joournal which accepts high quality resarch articles. The journal is issued monthly and is available to all researchers who are interested in publishing their scientific achievements.
“Fit for Health 2.0” , the European initiative supporting researchers in all stages of Health research and results valorisation, is now inviting you to publish or update your online expertise profile, if you are interested to participate in Horizon 2020 under thematic “Health, demographic change and wellbeing”. Read more
Liv Beathe Gransmo will have her public defence on Friday December 20, 2013.
Trial lecture: Thursday December 19, 2013, 12:15 pm.
Topic: “Importance of normal genetic variation for breast cancer risk, prognosis and therapy”
Public defence: Friday December 20, 2013, 10:15 am.
Place: Auditorium 1, BB-building, Jonas Lies vei 91
Title of dissertation: “MDM2 polymorphisms: The impact of four promoter variants on cancer risk”
1. opponent: Senior Scientist, ph.d. Shan Zienolddiny, National Institute of Occupational Health
2. opponent: Senior Scientist, ph.d. Anita Langerød, Norwegian Radium Hospital, Oslo
3. member of the committee: Associate Professor, ph.d. Maria C. Enger, University of Bergen
The public defence will be led by Professor Asbjørn Svardal
Anyone interested is welcome to attend
Supervisor: Per Eystein Lønning
The conference will take place on September 10-12, 2014 at the University of Cantaberia, Spain. Main theme is Clinical Risk Management. Click here for more information
In October 2014 two medical prizes will be awarded – Anders Jahres medical prize as reward for outstanding scientific work or research results within Nordic medicine, and Anders Jahres medical prize for young medical researchers in the Nordic countries.
Klikk her og her for mer informasjon
De fleste utlysningene for Horizon 2020 har nå blitt publisert. Klikk her for mer informasjon
Application form for parking spots at UiB 2014 is ready. Click here for form (In Norwegian)
This week’s Spotlight contains information on how to locate documents at the Participant Portal.
The announcements are aimed at the recruitment of skilled national and international candidates. Click here for BFS announcement, and click here for BMFS announcement.
SIU will arrange EEA/Norway Grants Contact Seminar in Oslo, February 3-4 2014. The aim of the seminar is to facilitate meetings between Norwegian and European institutions and academic environments. Click here for more information